Immunocore Holdings (IMCR) Net Margin (2023 - 2026)

Immunocore Holdings has disclosed Net Margin across 4 years of filings, most recently posting 12.16% for Q1 2026.

• Net Margin for Q1 2026 came in at 12.16%, up 685.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.69% (down 18.0% YoY), and the FY2025 annual result was 8.88%, up 759.0% from the prior year.
• Net Margin came in at 12.16% for Q1 2026 at Immunocore Holdings, up from 28.82% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 12.16% in Q1 2026 to a low of 35.58% in Q1 2023.
• The 4-year median for Net Margin is 15.42% (2024), against an average of 13.87%.
• Peak annual rise in Net Margin reached 3997 bps in 2025, while the deepest fall reached 1100 bps in 2025.
• Immunocore Holdings' Net Margin stood at 28.12% in 2023, then declined by 1 bps to 28.28% in 2024, then decreased by 2 bps to 28.82% in 2025, then surged by 142 bps to 12.16% in 2026.
• The last three Net Margin figures came in at 12.16% (Q1 2026), 28.82% (Q4 2025), and 0.17% (Q3 2025), per Business Quant data.